Imaging Inflammation in Alzheimer's Disease
Imaging Inflammation in Elders With Different Clinical and Biomarker Profiles of Alzheimer's Disease
Sponsor: National Institute on Aging (NIA)
This PHASE2 trial investigates Alzheimer's Disease and is currently completed. National Institute on Aging (NIA) leads this study, which shows 13 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Apr 2025 — Present [monthly]
Completed PHASE2
Status: Unknown → Completed
-
Oct 2024 — Apr 2025 [monthly]
Unknown PHASE2
Status: Enrolling By Invitation → Unknown
-
Sep 2024 — Oct 2024 [monthly]
Enrolling By Invitation PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation PHASE2
-
Sep 2022 — Jul 2024 [monthly]
Enrolling By Invitation PHASE2
▶ Show 8 earlier versions
-
Sep 2021 — Sep 2022 [monthly]
Enrolling By Invitation PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Enrolling By Invitation PHASE2
-
Aug 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE2
-
Feb 2019 — Aug 2020 [monthly]
Enrolling By Invitation PHASE2
-
Jun 2018 — Feb 2019 [monthly]
Enrolling By Invitation PHASE2
-
Jan 2018 — Jun 2018 [monthly]
Enrolling By Invitation PHASE2
Status: Recruiting → Enrolling By Invitation
-
Feb 2017 — Jan 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Aging (NIA)
- Patrick Lao
For direct contact, visit the study record on ClinicalTrials.gov .